Biomarin Pharmaceutical (BMRN) Raw Materials (2010 - 2021)
Biomarin Pharmaceutical (BMRN) recorded Raw Materials of $75.33 million in Q3 2021, up 2.0% from $73.86 million a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Raw Materials (2010 - 2021) Analysis & Trends
At the end of FY2020, Biomarin Pharmaceutical reported Raw Materials of $76.67 million, up 3.0% from FY2019.
- Annual Raw Materials has a five-year compound annual growth rate of 10.7% (FY2015 to FY2020).
- Across earlier years, Raw Materials came in at $74.44 million in FY2019 (-0.2%), $74.62 million in FY2018 (+49.6%), $49.88 million in FY2017 (-2.7%) and $51.25 million in FY2016 (+11.1%).
- Quarterly Raw Materials has ranged from $46.54 million in Q2 2018 to $83.72 million in Q2 2021 over the past five years.
- On a year-over-year basis, Raw Materials rose in six of the last eight quarters, with growth averaging 8.5%.
- Peak year-over-year performance for Raw Materials in the last five years was growth of 49.6% in Q4 2018, against a decline of 4.4% in Q1 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $83.72 million (Q2 2021), $78.57 million (Q1 2021) and $76.67 million (Q4 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 75.33 Mn |
| Jun 30, 2021 | 83.72 Mn |
| Mar 31, 2021 | 78.57 Mn |
| Dec 31, 2020 | 76.67 Mn |
| Sep 30, 2020 | 73.86 Mn |
| Jun 30, 2020 | 81.13 Mn |
| Mar 31, 2020 | 82.21 Mn |
| Dec 31, 2019 | 74.44 Mn |
| Sep 30, 2019 | 68.39 Mn |
| Jun 30, 2019 | 67.40 Mn |
| Mar 31, 2019 | 60.43 Mn |
| Dec 31, 2018 | 74.62 Mn |
| Sep 30, 2018 | 49.43 Mn |
| Jun 30, 2018 | 46.54 Mn |
| Mar 31, 2018 | 52.64 Mn |
| Dec 31, 2017 | 49.88 Mn |
| Sep 30, 2017 | 48.36 Mn |
| Jun 30, 2017 | 46.60 Mn |
| Mar 31, 2017 | 49.87 Mn |
| Dec 31, 2016 | 51.25 Mn |
API Access
Biomarin Pharmaceutical Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();